Gleevec and Enoxaparin sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gleevec (imatinib mesylate) and Enoxaparin sodium (enoxaparin sodium). Common drug interactions include cerebral haemorrhage among females and ischaemic stroke among males.

The phase IV clinical study analyzes what interactions people have when they take Gleevec and Enoxaparin sodium. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Gleevec?

Gleevec has active ingredients of imatinib mesylate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 35,415 Gleevec users. Check the latest studies of Gleevec.

What is Enoxaparin sodium?

Enoxaparin sodium has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 24,181 Enoxaparin sodium users. Check the latest studies of Enoxaparin sodium.



On Jul, 15, 2026

14 people who take Gleevec and Enoxaparin sodium together, and have interactions are studied.

Gleevec and Enoxaparin sodium drug interactions.

What are the common drug interactions of Gleevec and Enoxaparin Sodium, by gender? *:

female:

  1. Cerebral haemorrhage (bleeding within the brain)
  2. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  3. Hypertensive crisis
  4. Neoplasm malignant (cancer tumour)
  5. Neoplasm progression (growth of tumour)
  6. Thrombocytopenia (decrease of platelets in blood)
  7. Cough
  8. General physical health deterioration (weak health status)
  9. Haemoglobin decreased
  10. Lower limb fracture

male:

  1. Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Dehydration (dryness resulting from the removal of water)
  4. Disease progression
  5. Dyspnoea (difficult or laboured respiration)
  6. General physical health deterioration (weak health status)
  7. Groin pain
  8. Hospitalisation
  9. Hypoaesthesia (reduced sense of touch or sensation)
  10. Hypotension (abnormally low blood pressure)

What are the common drug interactions of Gleevec and Enoxaparin Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Blood creatinine increased
  4. C-reactive protein increased
  5. Cardiac failure
  6. Constipation
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  9. Dehydration (dryness resulting from the removal of water)
  10. Disease progression

What are the existing conditions these people have? *

  1. Dizziness: 5 people, 35.71%
  2. High Blood Pressure: 5 people, 35.71%
  3. Gastrointestinal Stromal Tumor: 3 people, 21.43%
  4. Urinary Tract Infection: 2 people, 14.29%
  5. Nausea And Vomiting: 2 people, 14.29%
  6. Anaemia (lack of blood): 2 people, 14.29%
  7. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 14.29%
  8. Gout (uric acid crystals building up in the body): 2 people, 14.29%
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 14.29%
  10. Hypercoagulation (increased tendency for clotting of the blood): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Gleevec and Enoxaparin sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Gleevec and Enoxaparin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gleevec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Enoxaparin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gleevec and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Enoxaparin sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on imatinib mesylate and enoxaparin sodium (the active ingredients of Gleevec and Enoxaparin sodium, respectively), and Gleevec and Enoxaparin sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: